NuScale's Revenue Plunged 99% Last Quarter, But the Stock Has Gained 1% So Far. Here's What Investors Need to Know.

NuScale Power reported Q2 revenue of ~$75k, down 99% from ~$8.0M a year ago, with an estimated ~$50M net loss—moves that could pressure the stock at the open. The article argues the revenue collapse is largely timing-related (prior-year one-off RoPower engineering work) and highlights that NuScale is “ready to deploy” with an NRC-approved design and a >60-supplier supply chain. The key missing ingredient remains a binding customer commitment/contract (discussed potential scale PPA with TVA via ENTRA1), making the outlook promising but dependent on future commercial sales.

Analysis

This is still an option on commercialization, not a report card on operating performance. The key market variable is not reported revenue; it is whether SMR converts engineering readiness into a binding, financeable utility commitment. Until that happens, the equity is effectively a long-duration call on project execution with a growing dilution overhang, so the current narrative support can fade quickly if the contract window slips another 1-2 quarters.

For suppliers such as HON, the near-term earnings impact is trivial; the bigger effect is reputational. A signed order would validate the nuclear supply chain and could lift sentiment across adjacent nuclear contractors and fuel-cycle names, but absent that, the read-through is mostly promotional. The second-order loser is the broader pre-revenue nuclear complex: if SMR cannot secure a marquee customer after years of readiness messaging, investors will likely demand proof-of-cash-flow from the whole segment.

The contrarian point is that consensus may be underpricing the binary nature of the next catalyst. A PPA/FID could force a sharp re-rate because expectations are low, but without it the stock shifts from 'commercially close' to 'serial capital raise' and that is a meaningful multiple compression risk over 1-3 months. The 6-18 month structural issue is financing: every quarter without contracted backlog increases the probability that future growth is funded by equity rather than operations.

Key Decisions for Investors

• SMR: do not chase strength until there is a binding PPA or FID; treat rallies as sellable event-driven moves, with the thesis invalidated by a signed TVA/ENTRA1-style contract or material project-financing disclosure.
• SMR put spread (3-6 months): use as a tactical hedge against a 1-3 month disappointment cycle; risk/reward is attractive if the market is paying for commercialization optionality without hard backlog.
• Relative value: long HON / short SMR for a diversified-vs.-binary commercialization pair; the long leg captures any delayed supply-chain benefit while the short leg isolates the dilution and execution risk. Keep sizing small if borrow is tight.
• Watchlist alert: if SMR announces a customer commitment, reassess immediately for a re-rating trade; if no announcement by the next 1-2 quarters, expect the stock to trade more like a financing story than a growth story.